News
Stay updated on market trends for AKRO. Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio? Check out ...
On Thursday, Akero Therapeutics', G. Walmsley Graham, made a $8.79M buy of AKRO, purchasing 200,000 shares at a cost of $43.94 a piece. Akero Therapeutics is trading down about 0.7% on the day Friday.
In trading on Tuesday, shares of Akero Therapeutics Inc (Symbol: AKRO) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $38.98 per share. By ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results